Nectin Therapeutics Obtained $5.4 Million Investment for Solid Tumors Immunotherapy Study
Nectin Therapeutics Ltd., a biotechnology company developing novel targeted immunotherapies, and Cancer Focus Fund, LP, a unique investment fund established in collaboration with The University of Texas MD Anderson Cancer…
Continue Reading
Nectin Therapeutics Obtained $5.4 Million Investment for Solid Tumors Immunotherapy Study